| Angela Ann Wingate, CRNA | |
|
3000 Mack Rd, Fairfield, OH 45014-5335 | |
| (214) 687-0496 | |
| (214) 687-9344 |
| Full Name | Angela Ann Wingate |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 3000 Mack Rd, Fairfield, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992000210 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | COA-12119NA (Ohio) | Primary |
| 163W00000X | Registered Nurse | 286052 (Ohio) | Secondary |
| Entity Name | Southwest Ohio Anesthesia Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588645188 PECOS PAC ID: 6901700640 Enrollment ID: O20031124000399 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
People may feel a flip-flop in their chest when they're under stress, haven't slept well or even during normal activity.
Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.
Researchers at Wake Forest Baptist Health have identified a novel mechanism and potential new therapeutic target for Alzheimer's disease.
A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.
› Verified 3 days ago
| Entity Name | Northstar Anesthesia Of Ohio Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417276429 PECOS PAC ID: 3173648300 Enrollment ID: O20100927000005 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
People may feel a flip-flop in their chest when they're under stress, haven't slept well or even during normal activity.
Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.
Researchers at Wake Forest Baptist Health have identified a novel mechanism and potential new therapeutic target for Alzheimer's disease.
A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.
› Verified 3 days ago
| Entity Name | Allied Anesthesia Professionals Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902107519 PECOS PAC ID: 1355522723 Enrollment ID: O20110218000579 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
People may feel a flip-flop in their chest when they're under stress, haven't slept well or even during normal activity.
Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.
Researchers at Wake Forest Baptist Health have identified a novel mechanism and potential new therapeutic target for Alzheimer's disease.
A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.
› Verified 3 days ago
| Entity Name | Ogi Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962776807 PECOS PAC ID: 8224290598 Enrollment ID: O20120502000531 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
People may feel a flip-flop in their chest when they're under stress, haven't slept well or even during normal activity.
Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.
Researchers at Wake Forest Baptist Health have identified a novel mechanism and potential new therapeutic target for Alzheimer's disease.
A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.
› Verified 3 days ago
| Entity Name | Dayton Anesthesia & Pain Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629401898 PECOS PAC ID: 8022245372 Enrollment ID: O20131212001655 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
People may feel a flip-flop in their chest when they're under stress, haven't slept well or even during normal activity.
Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.
Researchers at Wake Forest Baptist Health have identified a novel mechanism and potential new therapeutic target for Alzheimer's disease.
A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.
› Verified 3 days ago
| Entity Name | Cgi Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174914352 PECOS PAC ID: 0840518411 Enrollment ID: O20150410000268 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
People may feel a flip-flop in their chest when they're under stress, haven't slept well or even during normal activity.
Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.
Researchers at Wake Forest Baptist Health have identified a novel mechanism and potential new therapeutic target for Alzheimer's disease.
A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.
› Verified 3 days ago
| Entity Name | Southwest Ohio Anesthetists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518614122 PECOS PAC ID: 1951776459 Enrollment ID: O20230414002264 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
People may feel a flip-flop in their chest when they're under stress, haven't slept well or even during normal activity.
Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.
Researchers at Wake Forest Baptist Health have identified a novel mechanism and potential new therapeutic target for Alzheimer's disease.
A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela Ann Wingate, CRNA 6225 N. State Hwy 161, Ste. 200, Irving, TX 75038-2241 Ph: (214) 687-0496 | Angela Ann Wingate, CRNA 3000 Mack Rd, Fairfield, OH 45014-5335 Ph: (214) 687-0496 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
People may feel a flip-flop in their chest when they're under stress, haven't slept well or even during normal activity.
Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.
Researchers at Wake Forest Baptist Health have identified a novel mechanism and potential new therapeutic target for Alzheimer's disease.
A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated, the world's leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths.
› Verified 3 days ago
Misty Keeton, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3000 Mack Rd, Fairfield, OH 45014 Phone: 513-870-7000 | |
Michael Njuguna Kuria, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3000 Mack Rd, Fairfield, OH 45014 Phone: 513-870-7000 Fax: 717-653-6978 | |
Gerald Kistler, RN Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3000 Mack Rd, Fairfield, OH 45014 Phone: 513-672-3309 Fax: 513-672-3323 | |
Rita Thomas, RN Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3000 Mack Rd, Fairfield, OH 45014 Phone: 513-672-3309 Fax: 513-672-3323 | |
Janie M Mcelwain, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3000 Mack Rd, Fairfield, OH 45014 Phone: 513-870-7000 | |
Mark Koch, RN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3000 Mack Rd, Fairfield, OH 45014 Phone: 513-870-7000 | |
Rogers Tuwei, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3000 Mack Rd, Fairfield, OH 45014 Phone: 513-870-7000 |